Stuart Essig

Biography

 STUART M. ESSIG, Ph.D., currently serves as managing director of Prettybrook Partners LLC, investing in medical technology companies.He has been Integra LifeSciences Corporation's chairman of the Board of Directors since 2012, and a director since he joined Integra in 1997. He served as chief executive officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 20-year tenure with the company, Integra has grown revenues from $15 million to over $1 billion.Before joining Integra, Dr. Essig was managing director of the medical technology practice at Goldman, Sachs & Co. He had 10 years of broad healthcare experience at Goldman Sachs, serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.Dr. Essig has chaired audit, compensation and nominating and governance committees, served as lead director, and participated in CEO succession processes on the boards of numerous public companies, ranging in size from several hundred million dollars to almost $30 billion in levered market capitalization.In addition to Integra, Dr. Essig currently serves on the Board of Directors of SeaSpine Holdings Corporation (NASDAQ:SPNE) and Owens & Minor, Inc. (NYSE:OMI). He is also the chairman of the Board of Directors of private-equity backed Breg, Inc. He is an executive-in-residence at Cardinal Partners and a venture partner at Wellington Partners Advisory AG, both venture capital firms. He also serves as a senior advisor to TowerBrook Capital Partners and Water Street Healthcare Partners.  Dr. Essig is a founding investor member of Tigerlabs, a Princeton-based business accelerator. He serves on the Leadership Counsel of the Princeton University School of Engineering and Applied Sciences, and the NACD Compensation Committee Chair Advisory Counsel.

Research Interest

  Medical Technology